跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
在 國立陽明交通大學研發優勢分析平台 搜尋內容
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
Enhanced radiotherapy susceptibility in NSCLC through palbociclib-mediated PP5 inhibition
Chao Yuan Huang
, Li Ju Chen
, Grace Chen
, Cheng Yi Wang
*
,
Shiao Ya Hong
*
此作品的通信作者
醫學生物技術暨檢驗學系
研究成果
:
Article
›
同行評審
總覽
指紋
指紋
深入研究「Enhanced radiotherapy susceptibility in NSCLC through palbociclib-mediated PP5 inhibition」主題。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
Non-small Cell Lung Cancer (NSCLC)
100%
Enhanced Cancer Therapy
100%
Palbociclib
100%
Radioresistance
50%
Radiotherapy
50%
Combination Therapy
33%
Radiosensitivity
33%
Apoptosis
16%
Bioinformatics Analysis
16%
Overall Survival
16%
Novel Therapeutic Targets
16%
Valuable Insight
16%
DNA Damage
16%
Molecular Targets
16%
Autophagy
16%
High-level Expression
16%
Lung Cancer Tissue
16%
Cyclin-dependent Kinase 4 (CDK4)
16%
Kaplan-Meier Survival Analysis
16%
New Combination
16%
AMPK Activation
16%
Therapeutic Outcome
16%
Cellular Events
16%
Therapy Strategy
16%
Enhanced Efficacy
16%
AMPK Inhibitor
16%
Pharmacology, Toxicology and Pharmaceutical Science
Non Small Cell Lung Cancer
100%
Palbociclib
100%
Combination Therapy
33%
Overall Survival
16%
Molecular Target
16%
Immunology and Microbiology
Radioresistance
100%
Autophagy
20%
Cancer Tissue
20%
Overall Survival
20%
DNA Damage
20%
Bioinformatics
20%
Programmed Cell Death
20%